OABI
Price
$4.02
Change
+$0.64 (+18.93%)
Updated
Aug 17, 12:22 PM (EDT)
Capitalization
491.42M
92 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$7.30
Change
-$0.16 (-2.14%)
Updated
Aug 17, 03:37 PM (EDT)
Capitalization
290.47M
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OABI vs TRDA

OABI vs TRDA Comparison Chart in %
View a ticker or compare two or three
VS
OABI vs. TRDA commentary
Aug 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OABI is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2026
Stock price -- (OABI: $3.38 vs. TRDA: $7.46)
Brand notoriety: OABI and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OABI: 75% vs. TRDA: 41%
Market capitalization -- OABI: $491.42M vs. TRDA: $290.47M
OABI [@Biotechnology] is valued at $491.42M. TRDA’s [@Biotechnology] market capitalization is $290.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OABI’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • OABI’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, OABI is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OABI’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 7 bullish TA indicator(s).

  • OABI’s TA Score: 5 bullish, 5 bearish.
  • TRDA’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than OABI.

Price Growth

OABI (@Biotechnology) experienced а +9.74% price change this week, while TRDA (@Biotechnology) price change was +8.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.19%. For the same industry, the average monthly price growth was +0.59%, and the average quarterly price growth was +2909.64%.

Reported Earning Dates

OABI is expected to report earnings on Nov 17, 2026.

TRDA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+1.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OABI($491M) has a higher market cap than TRDA($290M). OABI YTD gains are higher at: 82.703 vs. TRDA (-27.432). OABI has higher annual earnings (EBITDA): -33.73M vs. TRDA (-174.46M). TRDA has more cash in the bank: 76.4M vs. OABI (49.1M). OABI has less debt than TRDA: OABI (19.7M) vs TRDA (49.8M). OABI has higher revenues than TRDA: OABI (28.9M) vs TRDA (5.74M).
OABITRDAOABI / TRDA
Capitalization491M290M169%
EBITDA-33.73M-174.46M19%
Gain YTD82.703-27.432-301%
P/E RatioN/A10.26-
Revenue28.9M5.74M504%
Total Cash49.1M76.4M64%
Total Debt19.7M49.8M40%
TECHNICAL ANALYSIS
Technical Analysis
OABITRDA
RSI
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
49%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
59%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OABI
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WRGCX23.600.19
+0.81%
Nomura Small Cap Growth C
FRVEX43.640.15
+0.34%
Fidelity Advisor Real Estate C
EICVX20.940.04
+0.19%
EIC Value A
JVMAX30.470.03
+0.10%
JHancock Disciplined Value Mid Cap A
COMZX31.42-0.06
-0.19%
DWS Digital Horizons Inst

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with ABCL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
-1.46%
ABCL - OABI
37%
Loosely correlated
+3.74%
VCYT - OABI
37%
Loosely correlated
-3.17%
INMB - OABI
37%
Loosely correlated
+4.33%
NKTX - OABI
36%
Loosely correlated
+1.30%
TRDA - OABI
35%
Loosely correlated
+0.13%
More